A new standard in research. A world of possibility.Discover the Peptivia standard

Research stacks / Intimacy & Stamina Stack

PEPTIVIAKisspeptin-1010 mgVIAL · RESEARCH USE ONLY1 × 10 mg
PEPTIVIAPT-14110 mgVIAL · RESEARCH USE ONLY2 × 10 mg
PEPTIVIAIpamorelin5 mgVIAL · RESEARCH USE ONLY1 × 5 mg
PEPTIVIABPC-15710 mgVIAL · RESEARCH USE ONLY2 × 10 mg
6 VIALS · 4 DISTINCT MATERIALS
Reproductive signals meet growth-axis research.

Intimacy & Stamina Stack

Explore kisspeptin and melanocortin signalling alongside ipamorelin and BPC-157. Four materials connect reproductive neuroscience, growth-hormone release and repair-related cell models in a transparent six-vial selection.

CURATED INDIVIDUAL ITEMS · TEST / DEMO
AT A GLANCE

Inside the stack

Kisspeptin-10

1 × 10 mg single vial · $109.99 CAD each

$109.99 CAD

Kisspeptin-10 is a short kisspeptin fragment used to explore reproductive-hormone signalling. Its interest centres on the kisspeptin receptor and upstream regulation of the reproductive axis.

  • Reproductive-axis signalling — The kisspeptin system connects upstream signals with GnRH-related endocrine biology.
  • Short-fragment identity — KP-10 is a ten-amino-acid fragment, distinct from kisspeptin-54.
  • Hormone physiology — Reviewed acute KP-10 experiments in healthy men measured luteinizing hormone and its pulse pattern; this is distinct from kisspeptin-54 evidence.
Individual profile & specifications

PT-141

2 × 10 mg single vial · $99.99 CAD each

$199.98 CAD

PT-141, also known as bremelanotide, is a melanocortin receptor agonist studied in sexual-response signalling. Its receptor-focused identity offers a neural perspective distinct from reproductive-hormone peptides.

  • Melanocortin receptors — Receptor activity is the starting point for understanding its neural signalling role.
  • Sexual-response research — Reviewed clinical findings describe a specific manufactured formulation and study population.
  • Distinct pathway — Its melanocortin identity differs from kisspeptin’s reproductive-axis pathway.
Individual profile & specifications

Ipamorelin

1 × 5 mg single vial · $59.99 CAD each

$59.99 CAD

Ipamorelin is a pentapeptide ghrelin-receptor agonist studied for growth-hormone release. It offers a distinct receptor pathway for exploring growth-axis signalling alongside GHRH analogues.

  • Ghrelin receptor — Its secretagogue identity centres on the ghrelin-receptor pathway.
  • Growth-hormone release — Preclinical research examines GH-release activity and selectivity.
  • Pathway comparison — A different receptor target makes it useful for comparing secretagogue and GHRH signalling.
Individual profile & specifications

BPC-157

2 × 10 mg single vial · $99.99 CAD each

$199.98 CAD

BPC-157 is an experimental 15-amino-acid peptide studied for repair-related cell behaviour. Rat tendon research explores cell migration, stress survival and the signals that organise tissue responses.

  • Tendon-cell migration — Rat tendon-derived preparations provide a model for exploring cell movement and outgrowth.
  • Stress response — Cell-survival experiments examine how tendon cells respond under stress.
  • Repair signalling — FAK and paxillin are measured signalling pathways, rather than human recovery endpoints.
Individual profile & specifications
WHY THIS STACK

How each component works

Kisspeptin-10 and PT-141 address different reproductive and neural signalling pathways. Ipamorelin adds ghrelin-receptor biology, while BPC-157 introduces tendon-cell movement and stress-survival findings. These are individual research roles, not evidence of improved intimacy or stamina in people.

Explore the evidence & study context

Kisspeptin-10

Human physiology

Kisspeptin-10 produced a rapid rise in measured luteinizing hormone in the 2011 experiments.

An acute hormone response is not a demonstrated fertility or sexual-performance benefit.

George et al., 2011 ↗
Human physiology

Infusion experiments reported changes in LH pulse frequency and size.

Small study groups and short observations do not establish broad clinical efficacy or safety.

George et al., 2011 ↗

PT-141

Official US label

The US indication is narrowly defined for acquired, generalized HSDD in premenopausal women; its mechanism for that indication is not fully known.

The approved formulation is not this research material; US labelling is not Canadian authorization.

US bremelanotide prescribing information ↗
Official US label

The label reports nausea, transient blood-pressure increases and hyperpigmentation among safety considerations.

The indication does not extend to performance enhancement, men or postmenopausal women.

US bremelanotide prescribing information ↗

Ipamorelin

Cells / animal

Ipamorelin stimulated growth-hormone release in rat pituitary cells and in rat and swine experiments.

The 1998 study is preclinical, not evidence of muscle, sleep or anti-ageing benefits.

Raun et al., 1998 ↗
Animal

In swine, ACTH and cortisol responses were not significantly different from those following GHRH stimulation.

Selectivity in that model does not establish safety in people or effects of a blend.

Raun et al., 1998 ↗

BPC-157

Cells / animal

Rat tendon explants showed increased outgrowth; cultured tendon cells showed greater survival under stress and migration.

Rat-derived preparations, not a human healing trial.

Chang et al., 2011 ↗
Cells

FAK and paxillin signalling changed, while cell proliferation was not directly increased.

Signalling and cell movement are not clinical recovery outcomes.

Chang et al., 2011 ↗

Specifications & questions

Are these premixed?

The stack contains separately labelled vials, not one combined mixture. A constituent such as GLOW or CJC/ipamorelin is itself a premixed blend, as named in the catalogue.

How is the price calculated?

The selected total is the sum of the current retail price of each constituent vial, multiplied by its displayed quantity. Two vials means two single-vial prices, not a bulk tier. No additional stack discount is applied.

Does adding this change a paid order?

No. The items enter your current demo bag together. Existing bag lines increase by their stated quantities; paid test orders remain unchanged. Checkout is simulated.

What handling information is available?

Format, strength and quantity are shown for each item. Storage, identity, purity and handling require verified batch-specific documentation. This collection supplies no dosing or cycle schedule.

Can component evidence prove the collection works?

No. Study findings retain their individual experimental context. A shared research theme does not establish the effects or safety of a combination.

A DIFFERENT QUESTION

Related collections

All stacks
PEPTIVIASelank10 mgVIAL · RESEARCH USE ONLY1 × 10 mg
PEPTIVIASemax10 mgVIAL · RESEARCH USE ONLY1 × 10 mg
2 VIALS · 2 DISTINCT MATERIALS
Focus & cognition

Focus & Calm Stack

Selank and Semax bring two complementary research questions into view: GABA-related signalling and neurotrophic pathways involved in learning and memory. A focused starting point for exploring stress-response and cognitive neuroscience.

  • 1 × Selank · 10 mg · $79.99 CAD each
  • 1 × Semax · 10 mg · $79.99 CAD each
PEPTIVIACJC-1295 with DAC5 mgVIAL · RESEARCH USE ONLY2 × 5 mg
PEPTIVIAIpamorelin5 mgVIAL · RESEARCH USE ONLY2 × 5 mg
PEPTIVIAMOTS-C10 mgVIAL · RESEARCH USE ONLY2 × 10 mg
6 VIALS · 3 DISTINCT MATERIALS
Growth & recovery

Muscle & Recovery Stack

Explore growth-hormone signalling and cellular adaptation with two vials each of CJC-1295 with DAC, ipamorelin and MOTS-c. This collection brings growth-axis and mitochondrial research into one clearly specified selection.

  • 2 × CJC-1295 with DAC · 5 mg · $149.99 CAD each
  • 2 × Ipamorelin · 5 mg · $59.99 CAD each
  • 2 × MOTS-C · 10 mg · $79.99 CAD each
6 single vials$569.94 CAD